| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |